Skip to main content

. 1978 Aug;38(2):339–343. doi: 10.1038/bjc.1978.208

Lymphocyte response to antigen stimulation as measured by fluorescence polarization (SCM test).

J A Pritchard, W H Sutherland

PMCID: PMC2009730 PMID: 698051

339

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cercek L., Cercek B. Apparent tumour specificity with the SCM test. Br J Cancer. 1975 Feb;31(2):252–253. doi: 10.1038/bjc.1975.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
Cercek L., Cercek B. Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a review. Eur J Cancer. 1977 Sep;13(9):903–915. doi: 10.1016/0014-2964(77)90166-9. [DOI] [PubMed] [Google Scholar]
Cercek L., Cercek B., Franklin C. I. Biophysical differentiation between lymphocytes from healthy donors, patients with malignant diseases and other disorders. Br J Cancer. 1974 May;29(5):345–352. doi: 10.1038/bjc.1974.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
Dickinson J. P., McDermott J. R., Smith J. K., Caspary E. A. A common tumour specific antigen. II. Further characterization of the whole antigen and of a cross-reacting antigen of normal tissues. Br J Cancer. 1974 Jun;29(6):425–432. doi: 10.1038/bjc.1974.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases. Br J Cancer. 1976 Jul;34(1):1–6. doi: 10.1038/bjc.1976.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease. Br J Cancer Suppl. 1973 Aug;1:229–236. [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES